Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar
Hiam Chemaitelly, Patrick Tang, Mohammad R. Hasan, et al.
New England Journal of Medicine (2021) Vol. 385, Iss. 24
Open Access | Times Cited: 557

Showing 1-25 of 557 citing articles:

Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic
Salim S. Abdool Karim, Quarraisha Abdool Karim
The Lancet (2021) Vol. 398, Iss. 10317, pp. 2126-2128
Open Access | Times Cited: 1298
Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression
Daniel R. Feikin, Melissa M. Higdon, Laith J. Abu‐Raddad, et al.
The Lancet (2022) Vol. 399, Iss. 10328, pp. 924-944
Open Access | Times Cited: 1108
The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic
Markus Hoffmann, Nadine Krüger, Sebastian Schulz, et al.
Cell (2021) Vol. 185, Iss. 3, pp. 447-456.e11
Open Access | Times Cited: 878
Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants
Emma K. Accorsi, Amadea Britton, Katherine E. Fleming-Dutra, et al.
JAMA (2022) Vol. 327, Iss. 7, pp. 639-639
Open Access | Times Cited: 646
Protection against SARS-CoV-2 after Covid-19 Vaccination and Previous Infection
Victoria Hall, Sarah Foulkes, Ferdinando Insalata, et al.
New England Journal of Medicine (2022) Vol. 386, Iss. 13, pp. 1207-1220
Open Access | Times Cited: 637
Effects of Previous Infection and Vaccination on Symptomatic Omicron Infections
Heba N. Altarawneh, Hiam Chemaitelly, Houssein H. Ayoub, et al.
New England Journal of Medicine (2022) Vol. 387, Iss. 1, pp. 21-34
Open Access | Times Cited: 484
Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial
Alasdair Munro, Leila Janani, Victoria Cornelius, et al.
The Lancet (2021) Vol. 398, Iss. 10318, pp. 2258-2276
Open Access | Times Cited: 430
BNT162b2 and mRNA-1273 COVID-19 vaccine effectiveness against the SARS-CoV-2 Delta variant in Qatar
Patrick Tang, Mohammad R. Hasan, Hiam Chemaitelly, et al.
Nature Medicine (2021) Vol. 27, Iss. 12, pp. 2136-2143
Open Access | Times Cited: 419
Advances in COVID-19 mRNA vaccine development
Enyue Fang, Xiaohui Liu, Miao Li, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 414
Duration of Protection against Mild and Severe Disease by Covid-19 Vaccines
Nick Andrews, Elise Tessier, Julia Stowe, et al.
New England Journal of Medicine (2022) Vol. 386, Iss. 4, pp. 340-350
Open Access | Times Cited: 381
Effect of mRNA Vaccine Boosters against SARS-CoV-2 Omicron Infection in Qatar
Laith J. Abu‐Raddad, Hiam Chemaitelly, Houssein H. Ayoub, et al.
New England Journal of Medicine (2022) Vol. 386, Iss. 19, pp. 1804-1816
Open Access | Times Cited: 367
SARS-CoV-2 Omicron has extensive but incomplete escape of Pfizer BNT162b2 elicited neutralization and requires ACE2 for infection
Sandile Cele, Laurelle Jackson, David S. Khoury, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 344
SARS-CoV-2 breakthrough infections in vaccinated individuals: measurement, causes and impact
Marc Lipsitch, Florian Krammer, Gili Regev‐Yochay, et al.
Nature reviews. Immunology (2021) Vol. 22, Iss. 1, pp. 57-65
Open Access | Times Cited: 311
Safety and Efficacy of a Third Dose of BNT162b2 Covid-19 Vaccine
Edson Duarte Moreira, Nicholas Kitchin, Xia Xu, et al.
New England Journal of Medicine (2022) Vol. 386, Iss. 20, pp. 1910-1921
Open Access | Times Cited: 311
Risk of infection, hospitalisation, and death up to 9 months after a second dose of COVID-19 vaccine: a retrospective, total population cohort study in Sweden
Peter Nordström, Marcel Ballin, Anna Nordström
The Lancet (2022) Vol. 399, Iss. 10327, pp. 814-823
Open Access | Times Cited: 281
The changing epidemiology of SARS-CoV-2
Katia Koelle, Michael A. Martin, Rustom Antia, et al.
Science (2022) Vol. 375, Iss. 6585, pp. 1116-1121
Open Access | Times Cited: 270
Unadjuvanted intranasal spike vaccine elicits protective mucosal immunity against sarbecoviruses
Tianyang Mao, Benjamin Israelow, Mario A. Peña-Hernández, et al.
Science (2022) Vol. 378, Iss. 6622
Open Access | Times Cited: 253
SARS-CoV-2 vaccine protection and deaths among US veterans during 2021
Barbara A. Cohn, Piera M. Cirillo, Caitlin C. Murphy, et al.
Science (2021) Vol. 375, Iss. 6578, pp. 331-336
Open Access | Times Cited: 244
Effectiveness of COVID-19 vaccines against SARS-CoV-2 variants of concern: a systematic review and meta-analysis
Baoqi Zeng, Le Gao, Qingxin Zhou, et al.
BMC Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 241
SARS-CoV-2 reinfections: Overview of efficacy and duration of natural and hybrid immunity
Stefan Pilz, Verena Theiler‐Schwetz, Christian Trummer, et al.
Environmental Research (2022) Vol. 209, pp. 112911-112911
Open Access | Times Cited: 238
The unintended consequences of COVID-19 vaccine policy: why mandates, passports and restrictions may cause more harm than good
Kevin Bardosh, Alexandre de Figueiredo, Rachel Gur‐Arie, et al.
BMJ Global Health (2022) Vol. 7, Iss. 5, pp. e008684-e008684
Open Access | Times Cited: 236
SARS-CoV-2 vaccine effectiveness against infection, symptomatic and severe COVID-19: a systematic review and meta-analysis
Paddy Ssentongo, Anna E. Ssentongo, Navya Voleti, et al.
BMC Infectious Diseases (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 226
The germinal centre B cell response to SARS-CoV-2
Brian J. Laidlaw, Ali H. Ellebedy
Nature reviews. Immunology (2021) Vol. 22, Iss. 1, pp. 7-18
Open Access | Times Cited: 220
BNT162b2 Vaccine Booster and Mortality Due to Covid-19
Ronen Arbel, Ariel Hammerman, Ruslan Sergienko, et al.
New England Journal of Medicine (2021) Vol. 385, Iss. 26, pp. 2413-2420
Open Access | Times Cited: 217
Duration of mRNA vaccine protection against SARS-CoV-2 Omicron BA.1 and BA.2 subvariants in Qatar
Hiam Chemaitelly, Houssein H. Ayoub, Sawsan AlMukdad, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 216
Page 1 - Next Page

Scroll to top